| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.032 | 0.9 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |